The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government.
Know the risks and potential benefits of clinical studies and talk to your health care provider before participating.
Read our disclaimer for details.
Observational prospective study to evaluate the feasibility, effectiveness and the rate of complications of the XLIF (Extreme Lateral Interbody Fusion) performed in prone position to treat spinal diseases of the lumbar region.
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.
Layout table for eligibility information
Ages Eligible for Study:
18 Years and older (Adult, Older Adult)
Sexes Eligible for Study:
Accepts Healthy Volunteers:
Patients affected by a lumbar spinal disease, indicated for surgery requiring a lateral XLIF approach to the lumbar spine, eligible to perform the approach in a prone position.
Age ≥ 18
Patients suffering from lumbar spinal disease that requires a circumferential fusion
Patients suitable to undergo spinal fusion with an XLIF technique (according to the label indication/contraindications)
Patients who are willing and able to provide written informed consent to surgery and study
a congenital or post-traumatic vertebral abnormality at the target level
patients with a previous abdominal retroperitoneal surgery
patients that refuses/not suitable to undergo a XLIF surgery in prone position
subjects that are unable to provide a written informed consent to surgery and study